• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Inspire Medical Systems Inc.

Inspire Medical faces DOJ investigation

February 11, 2025 By Sean Whooley

Inspire Medical Systems shares dipped — but have since mostly recovered — following news of a government investigation following fourth-quarter results. As of midday today, INSP shares were up more than 2% to $185 apiece. (They were down more than 5% over the past five days.) The company disclosed yesterday evening that on Jan. 17, […]

Filed Under: Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Respiratory, Wall Street Beat Tagged With: Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical sales grow more than 30% in Street-beating Q3, full-year guidance raised

November 5, 2024 By Sean Whooley

Inspire Medical Systems (NYSE:INSP) shares are up today on third-quarter results that came in ahead of the consensus forecast. Shares of INSP were up more than 3% to $199.42 apiece by the afternoon today. Yesterday evening, the Minneapolis-based developer of neurostimulation technology for treating sleep apnea reported profits of $18.5 million. That equals 60¢ per […]

Filed Under: Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Respiratory, Wall Street Beat Tagged With: Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical beats The Street in Q2, ups guidance

August 7, 2024 By Chris Newmarker

Inspire Medical Systems (NYSE: INSP) continues to report good news, as sales grow for the maker of implantable neuromodulation devices to treat sleep apnea. Minneapolis-based Inspire earned $9.8 million, or 32¢ per share, on $195.9 million in revenue for the quarter that ended June 30, 2024. That compares with a loss of $11.9 million, or […]

Filed Under: Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Respiratory, Wall Street Beat Tagged With: Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical wins FDA nod for next-gen sleep apnea neurostim

August 2, 2024 By Sean Whooley

Inspire Medical Systems announced today that it received FDA approval for its Inspire V therapy system. Inspire V includes a next-generation neurostimulator and associated Bluetooth patient remote and physician programmer. It marks the latest innovation for the Minneapolis-based obstructive sleep apnea (OSA) treatment developer. The pacemaker-like device delivers mild electrical stimulation to the hypoglossal nerve, […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical stock ticks up on 30% Q2 sales growth, increased guidance

July 29, 2024 By Sean Whooley

Inspire Medical Systems today announced preliminary second-quarter results that include 30% year-over-year revenue growth. Shares of INSP grew more than 5% to $132.56 in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The developer of neuromodulation tech for treating sleep apnea also […]

Filed Under: Business/Financial News, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Respiratory, Wall Street Beat Tagged With: Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical appoints chief people officer

July 22, 2024 By Danielle Kirsh

Inspire Medical Systems today announced it appointed Melissa Mann as Chief People Officer, effective immediately. Mann has over 25 years of experience in human capital management. She joins the Minneapolis-based sleep therapy company from UnitedHealth Group, where she served for eight years in its Optum division. There, she led the human capital teams for Optum […]

Filed Under: Business/Financial News, Implants Tagged With: Inspire Medical Systems Inc., Personnel Moves

Inspire sleep apnea therapy wins CE mark under the MDR

July 19, 2024 By Chris Newmarker

Inspire Medical Systems announced today that its Inspire therapy has secured its CE mark under the EU’s Medical Device Regulation.  Going into effect in 2021, the tighter regulations in the European Union have been a major challenge for medical device companies. With worries growing that medtech companies would pull products out of the EU because […]

Filed Under: Neuromodulation/Neurostimulation, Regulatory/Compliance, Respiratory Tagged With: EU MDR, Inspire Medical, Inspire Medical Systems Inc., sleep apnea

Inspire Medical has a serious implantable pulse generator recall

July 9, 2024 By Sean Whooley

The FDA labeled a recall of Inspire Medical Systems (NYSE:INSP) implantable pulse generators (IPGs) Class I, the most serious kind. Inspire initiated a recall of its IV IPG on June 17. The recall involves removing certain devices from where they are used or sold. It extends to 32 devices of the Model 3028 IPG. To […]

Filed Under: Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Inspire Medical, Inspire Medical Systems Inc.

Inspire Medical stock falls despite 40% Q4 sales growth, Wall Street beats

February 7, 2024 By Sean Whooley

Inspire Medical Systems (NYSE:INSP) shares took a hit today despite fourth-quarter results that beat the consensus forecast. Shares of INSP fell nearly 7% at $210.35 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed even. The Minneapolis-based maker of neuromodulation implants for […]

Filed Under: Business/Financial News, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Respiratory, Wall Street Beat Tagged With: Inspire Medical Systems Inc.

Inspire Medical CEO takes over as board chair

February 5, 2024 By Sean Whooley

Inspire Medical Systems (NYSE:INSP) announced today that Marilyn Carlson Nelson retired as chair of the company’s board of directors. The Minneapolis-based sleep apnea treatment developer appointed current CEO Timothy Herbert to the additional role of board chair. Herbert’s appointment goes into effect after the company’s annual meeting of stockholders on May 2, 2024. Nelson became […]

Filed Under: Business/Financial News, Implants, Neurological, Neuromodulation/Neurostimulation, Respiratory Tagged With: Inspire Medical Systems Inc., Personnel Moves

Longtime Inspire Medical board member Dr. Jerry Griffin to retire

January 26, 2024 By Sean Whooley

Inspire Medical Systems (NYSE:INSP) announced today that Dr. Jerry C. Griffin intends to retire from its board of directors. Griffin plans to retire at the conclusion of the company’s annual meeting of stockholders on May 2, 2024. The longtime director joined the Inspire board in 2008 as one of the original board members. He joined […]

Filed Under: Business/Financial News, Implants, Neurological, Neuromodulation/Neurostimulation, Respiratory Tagged With: Inspire Medical Systems Inc., Personnel Moves

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy